Fox Chase Cancer Center’s Post

Adaptive radiation therapy is better for Head and Neck Cancer patients. “Conclusion: ART replanning appears to be a sustainable strategy to minimize toxicity by improving normal tissue sparing. Furthermore, it can enhance target volume coverage by correctly determining the specific dose to be delivered to the tumor. In conclusion, this review confirmed that ART benefits dosimetric, clinical/therapeutic, and toxicity outcomes.” Head and Neck Cancer Australia Radiation Oncology: Targeting Cancer #headandneckcancer #radiationtherapy #adaptive

In the treatment of cancer patients, irradiation can be adapted anew each day to the position of the tumor and conditions in the body.

In the treatment of cancer patients, irradiation can be adapted anew each day to the position of the tumor and conditions in the body.

Kudos to Tugce Kutuk, MD, MS and Ranjini Tolakanahalli, PhD, DABR from Miami Cancer Institute for leading this project for which results are now published in the brachytherapy journal. This study highlights the effectiveness of a surgically targeted radiation therapy (STaRT) approach using Cesium-131 compared to external beam radiotherapy. It suggests that STaRT can effectively treat recurrent brain tumors by delivering higher radiation doses and achieving an equivalent or greater biological effective dose up to 3 mm from the resection edge. Link to article: https://lnkd.in/gwqURWpD Humbled to have contributed to this study and share our results. #BrainCancer #CancerCare #CancerResearch

A targeted radiation therapy that lasts only 15 minutes, instead of 45 minutes. Plus: an even more precise, real-time treatment of the tumor. These are the two goals of a new study by UMC Utrecht to further innovate the MR-Linac, which is coordinated by Martin Fast and Bas Raaymakers. NWO has granted 1.7 million euros to this research project, called ART-PIVOT.  In this consortium, UMC Utrecht teams up with AimValley, Elekta, IBA Quasar and Medscint. “Having to lie still for 45 minutes can be quite uncomfortable for patients. It also increases the chances of unacceptable anatomical motion during treatment. Therefore, we would like to speed up every aspect of the process, streamlining the procedure for patients", says Martin Fast. “By doing so, we will be able to treat more patients with the MR-Linac as well. Our goal is to have made the treatment time of 15 minutes standard in five years' time.” Congratulations Martin, Bas and consortium partners! #cancerresearch #mrlinac UMC Utrecht | Cancer Research UMC Utrecht | NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) | Martin Fast | Bas Raaymakers | AimValley | Elekta | IBA Quasar | Medscint

Explore the potential applications of artificial intelligence in thoracic radiation oncology: Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, continue their analysis in ILCN. https://bit.ly/3UGVBoG #LCSM

I'm thrilled to announce the release of the much-anticipated 4th Edition of "Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects." The new edition was commissioned by Elsevier Senior Acquisitions Editor Linda Buschman and edited by Hasan Murshed, (Hope Regional Cancer Center). This comprehensive edition is an essential resource for all professionals in radiation oncology. From foundational principles to cutting-edge techniques like #SRS, #SBRT, #protontherapy, and #immunotherapy, this book covers it all. New chapters on adaptive radiotherapy and artificial intelligence in radiation therapy reflect the latest advancements in the field. Detailed coverage of IMRT and IGRT techniques, alongside evidence-based treatment approaches from landmark studies, ensures that this book remains a vital reference for mastering the art and science of radiation oncology.

#PaperoftheDay: "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation therapy in prostate cancer" DOI ⬇️ https://lnkd.in/esX77r9a #cancer #prostatecancer #research #openaccess #peerreviewed #journalpublication #publishing

The University of Wisconsin Carbone Cancer Center is now home to the Initiative for Theranostics and Particle Therapy. This initiative will foster collaboration between experts across medical oncology, radiation oncology, radiology, nuclear medicine, medical physics and other specialties to accelerate precision radiation therapy and imaging for patients treated through the UW Health | Carbone Cancer Center. A key focus of the initiative will be translational research, or research that is designed to benefit human health. Investigators will assess how particle beam radiation may be effective to treat cancers that are difficult to treat using conventional radiation therapy, how diagnostic and treatment steps can be combined into a single step referred to as theranostics, and how radiation treatment plans can be personalized for each patient. The University of Wisconsin–Madison is the perfect setting for this initiative, according to Dr. Zachary Morris, co-director of the initiative, radiation oncologist at UW Carbone and associate professor of human oncology at the University of Wisconsin School of Medicine and Public Health. “We have a unique combination of unparalleled strengths here at UW,” he said. Read more: https://lnkd.in/d9vXBiXB #cancerresearch #curecancer